These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21863627)

  • 21. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.
    Torres-Puente M; Cuevas JM; Jiménez-Hernández N; Bracho MA; García-Robles I; Carnicer F; del Olmo J; Ortega E; Moya A; González-Candelas F
    J Med Virol; 2008 Feb; 80(2):247-53. PubMed ID: 18098147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning of the immunodominant regions of hepatitis C virus type III and IV by immunoscreening.
    Sato A; Kazami J; Arima T; Nakamura H; Kunitomo T
    Acta Virol; 1993; 37(2-3):132-42. PubMed ID: 7692715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
    Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2009 Jun; 81(6):1032-9. PubMed ID: 19382270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel protein binding to hepatitis C virus core protein.
    Chen YR; Chen TY; Zhang SL; Lin SM; Zhao YR; Ye F; Zhang X; Shi L; Dang SS; Liu M
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1300-4. PubMed ID: 19486448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein.
    Shimoike T; Koyama C; Murakami K; Suzuki R; Matsuura Y; Miyamura T; Suzuki T
    Virology; 2006 Feb; 345(2):434-45. PubMed ID: 16297950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein.
    Yamanaka T; Uchida M; Doi T
    Biochem Biophys Res Commun; 2002 Jun; 294(3):521-7. PubMed ID: 12056797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein.
    Nakai K; Okamoto T; Kimura-Someya T; Ishii K; Lim CK; Tani H; Matsuo E; Abe T; Mori Y; Suzuki T; Miyamura T; Nunberg JH; Moriishi K; Matsuura Y
    J Virol; 2006 Nov; 80(22):11265-73. PubMed ID: 16971440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Processing of hepatitis C virus core protein is regulated by its C-terminal sequence.
    Kato T; Miyamoto M; Furusaka A; Date T; Yasui K; Kato J; Matsushima S; Komatsu T; Wakita T
    J Med Virol; 2003 Mar; 69(3):357-66. PubMed ID: 12526046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational features of truncated hepatitis C virus core protein in virus-like particles.
    Rodriguez-Casado A; Molina M; Carmona P
    Biopolymers; 2006 Jul; 82(4):334-8. PubMed ID: 16475155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M; Enomoto N; Murakami T; Sakuma I; Asahina Y; Yamamoto C; Ikeda T; Tozuka S; Izumi N; Marumo F; Sato C
    Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antigenicities of groups I and II hepatitis C virus].
    Kohara M
    Nihon Rinsho; 1993 Feb; 51(2):338-43. PubMed ID: 7681884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Core protein of hepatitis C virus expressed in transgenic mice is associated with the expression of Fas molecule].
    Tan W; Lang Z; Cong Y; Chen G; Miao J; Zhan M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):205-7. PubMed ID: 15617329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
    J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein.
    Boumlic A; Nominé Y; Charbonnier S; Dalagiorgou G; Vassilaki N; Kieffer B; Travé G; Mavromara P; Orfanoudakis G
    FEBS J; 2010 Feb; 277(3):774-89. PubMed ID: 20067524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression studies of the HCV-1a core+1 open reading frame in mammalian cells.
    Vassilaki N; Boleti H; Mavromara P
    Virus Res; 2008 May; 133(2):123-35. PubMed ID: 18243391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.